IBDEI1X8 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30685,0)
 ;;=Q61.9^^123^1581^2
 ;;^UTILITY(U,$J,358.3,30685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30685,1,3,0)
 ;;=3^Cystic Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,30685,1,4,0)
 ;;=4^Q61.9
 ;;^UTILITY(U,$J,358.3,30685,2)
 ;;=^5018800
 ;;^UTILITY(U,$J,358.3,30686,0)
 ;;=Q61.2^^123^1581^6
 ;;^UTILITY(U,$J,358.3,30686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30686,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,30686,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,30686,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,30687,0)
 ;;=Q61.5^^123^1581^4
 ;;^UTILITY(U,$J,358.3,30687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30687,1,3,0)
 ;;=3^Medullary Cystic Kidney
 ;;^UTILITY(U,$J,358.3,30687,1,4,0)
 ;;=4^Q61.5
 ;;^UTILITY(U,$J,358.3,30687,2)
 ;;=^67073
 ;;^UTILITY(U,$J,358.3,30688,0)
 ;;=Z82.71^^123^1581^3
 ;;^UTILITY(U,$J,358.3,30688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30688,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,30688,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,30688,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,30689,0)
 ;;=Q61.5^^123^1581^5
 ;;^UTILITY(U,$J,358.3,30689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30689,1,3,0)
 ;;=3^Medullary Sponge Kidney
 ;;^UTILITY(U,$J,358.3,30689,1,4,0)
 ;;=4^Q61.5
 ;;^UTILITY(U,$J,358.3,30689,2)
 ;;=^67073
 ;;^UTILITY(U,$J,358.3,30690,0)
 ;;=Q61.3^^123^1581^7
 ;;^UTILITY(U,$J,358.3,30690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30690,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,30690,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,30690,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,30691,0)
 ;;=E11.65^^123^1582^11
 ;;^UTILITY(U,$J,358.3,30691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30691,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,30691,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,30691,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,30692,0)
 ;;=E10.65^^123^1582^6
 ;;^UTILITY(U,$J,358.3,30692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30692,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,30692,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,30692,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,30693,0)
 ;;=E11.21^^123^1582^9
 ;;^UTILITY(U,$J,358.3,30693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30693,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,30693,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,30693,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,30694,0)
 ;;=E10.29^^123^1582^3
 ;;^UTILITY(U,$J,358.3,30694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30694,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,30694,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,30694,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,30695,0)
 ;;=E10.21^^123^1582^4
 ;;^UTILITY(U,$J,358.3,30695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30695,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,30695,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,30695,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,30696,0)
 ;;=E11.40^^123^1582^10
 ;;^UTILITY(U,$J,358.3,30696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30696,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,30696,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,30696,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,30697,0)
 ;;=E10.40^^123^1582^5
 ;;^UTILITY(U,$J,358.3,30697,1,0)
 ;;=^358.31IA^4^2
